BioNews Texas | BOLERO-3: Everolimus Might Help Patients Overcome Trastuzumab Resistance OncLive Adding the mTOR inhibitor everolimus to conventional therapy slowed the progression of trastuzumab-resistant advanced breast cancer, and in the process, provided clues to the origin of trastuzumab resistance. The findings came from the results of the ... MD Anderson Researchers Reveal That Genetic Alterations Affect Everolimus ... |
